3,7-diazabicyclo(3.3.1)nonane has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agostinelli, E; Bey, L; Hilal, A; Kaldybayeva, AB; Komarova, MV; Malmakova, AY; Neborak, EV; Ploskonos, MV; Tveritinova, AS; Yu, VK; Zhdanov, DD | 1 |
| Bachmann, M; Bergmann, R; Comba, P; Hegedüs, N; Hunoldt, S; Martínez, IIS; Máthé, D; Matterna, M; Ruehl, CL; Singh, G; Stephan, H; Zarschler, K | 1 |
| Gündisch, D; Tomassoli, I | 1 |
1 review(s) available for 3,7-diazabicyclo(3.3.1)nonane and Benign Neoplasms
| Article | Year |
|---|---|
Bispidine as a Privileged Scaffold.
Topics: Anti-Infective Agents; Antidotes; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Humans; Ion Channels; Neoplasms; Platelet Aggregation Inhibitors; Radioligand Assay; Receptors, Cell Surface | 2016 |
2 other study(ies) available for 3,7-diazabicyclo(3.3.1)nonane and Benign Neoplasms
| Article | Year |
|---|---|
Anticancer Cytotoxic Activity of Bispidine Derivatives Associated with the Increasing Catabolism of Polyamines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Neoplasms; Polyamines; Rats; Structure-Activity Relationship | 2022 |
Versatile Bispidine-Based Bifunctional Chelators for
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cetuximab; Chelating Agents; Coordination Complexes; Copper; Cycloaddition Reaction; Humans; Mice; Microscopy, Fluorescence; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Transplantation, Heterologous | 2020 |